|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
폐암종류 > 비소세포폐암 |
|
|
|
|
|
Total : 30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No |
Gene |
CHR |
SNV |
NR/R |
Mutation Type |
Amino Acid |
Strand |
Reference |
|
|
|
|
|
|
31 |
EGFR |
7p11.2 |
rs121913420 |
G/A |
missense |
p.E734K |
1 |
Rajasekaran et al., 2010, Appl.
Biochem. Biotechnol. |
|
|
|
|
|
|
32 |
EGFR |
7p11.2 |
rs121913430 |
G/A |
missense |
p.G735S |
1 |
Massarelli et al., 2013, Lung Cancer. |
|
|
|
|
|
|
33 |
EGFR |
7p11.2 |
rs121913466 |
T/C |
missense |
p.V742A |
1 |
Kancha et al., 2009, Clin. Cancer Res. |
|
|
|
|
|
|
34 |
EGFR |
7p11.2 |
rs121913427 |
G/A |
missense |
p.E746K |
1 |
MacConaill et al., 2014, J Mol Diagn. |
|
|
|
|
|
|
35 |
EGFR |
7p11.2 |
rs121913229 |
G/C |
missense |
p.A750P |
1 |
Lee
et al., 2012, Lung Cancer. |
|
|
|
|
|
|
36 |
EGFR |
7p11.2 |
rs121913464 |
C/A |
missense |
p.S752Y |
1 |
MacConaill et al., 2014, J Mol Diagn. |
|
|
|
|
|
|
37 |
EGFR |
7p11.2 |
rs121913231 |
C/T |
missense |
p.P753S |
1 |
Engelman et al., 2007, Cancer Res. |
|
|
|
|
|
|
38 |
EGFR |
7p11.2 |
rs121913418 |
G/A |
missense |
p.D761N |
1 |
Kancha et al., 2009, Clin. Cancer Res. |
|
|
|
|
|
|
39 |
EGFR |
7p11.2 |
rs121913418 |
G/T |
missense |
p.D761Y |
1 |
Tokumo et al., 2006, Lung Cancer. |
|
|
|
|
|
|
40 |
EGFR |
7p11.2 |
rs121913465 |
G/T |
missense |
p.S768I |
1 |
Fu et al., 2008, Oncogene. |
|
|
|
|
|
|
41 |
EGFR |
7p11.2 |
rs121913432 |
A/G |
missense |
p.H773R |
1 |
González Manzano et al., 2008, Clin
Transl Oncol. |
|
|
|
|
|
|
42 |
EGFR |
7p11.2 |
rs121434569 |
C/T |
missense |
p.T790M |
1 |
Lynch et al., 2004, N. Engl. J. Med. |
|
|
|
|
|
|
43 |
EGFR |
7p11.2 |
rs1057519861 |
T/A |
missense |
p.C797S |
1 |
Thress et al., 2015, Nat. Med. |
|
|
|
|
|
|
44 |
EGFR |
7p11.2 |
rs121913443 |
C/A |
missense |
p.L858M |
1 |
Rajasekaran et al., 2010, Appl. Biochem.
Biotechnol. |
|
|
|
|
|
|
45 |
EGFR |
7p11.2 |
rs1057519847 |
CT/AG |
missense |
p.L858R |
1 |
MacConaill et al., 2014, J Mol Diagn. |
|
|
|
|
|
|
46 |
EGFR |
7p11.2 |
rs121434568 |
T/G |
missense |
p.L858R |
1 |
Lynch et al., 2004, N. Engl. J. Med. |
|
|
|
|
|
|
47 |
EGFR |
7p11.2 |
rs121434568 |
T/A |
missense |
p.L858Q |
1 |
MacConaill et al., 2014, J Mol Diagn. |
|
|
|
|
|
|
48 |
EGFR |
7p11.2 |
rs1057519848 |
TG/GT |
missense |
p.L858R |
1 |
MacConaill et al., 2014, J Mol Diagn. |
|
|
|
|
|
|
49 |
EGFR |
7p11.2 |
rs121913444 |
T/A |
missense |
p.L861Q |
1 |
Lynch et al., 2004, N. Engl. J. Med. |
|
|
|
|
|
|
50 |
ERCC2 |
19q13.32 |
rs13181 |
T/G |
missense |
p.K751Q |
-1 |
Gandara et al., 2009, J. Clin. Oncol. |
|
|
|
|
|
|
51 |
ETS2 |
21 |
- |
A/G |
synonymous |
p.P341 |
1 |
Hong
et al., 2016, Oncotarget. |
|
|
|
|
|
|
52 |
KIT |
4q12 |
rs121913513 |
T/C |
missense |
p.L576P |
1 |
Antonescu et al., 2007, Int. J. Cancer. |
|
|
|
|
|
|
53 |
KRAS |
12p12.1 |
rs1057519725 |
G/A |
missense |
p.A146V |
-1 |
Van Allen et al., 2014, Nat. Med. |
|
|
|
|
|
|
54 |
KRAS |
12p12.1 |
rs17851045 |
T/A |
missense |
p.Q61H |
-1 |
Brose et al., 2002, Cancer Res. |
|
|
|
|
|
|
55 |
KRAS |
12p12.1 |
rs17851045 |
T/G |
missense |
p.Q61H |
-1 |
Brose et al., 2002, Cancer Res. |
|
|
|
|
|
|
56 |
KRAS |
12p12.1 |
rs121913240 |
T/A |
missense |
p.Q61L |
-1 |
Brose et al., 2002, Cancer Res. |
|
|
|
|
|
|
57 |
KRAS |
12p12.1 |
rs121913240 |
T/C |
missense |
p.Q61R |
-1 |
Brose et al., 2002, Cancer Res. |
|
|
|
|
|
|
58 |
KRAS |
12p12.1 |
rs121913238 |
G/T |
missense |
p.Q61K |
-1 |
Brose et al., 2002, Cancer Res. |
|
|
|
|
|
|
59 |
KRAS |
12p12.1 |
rs112445441 |
C/G |
missense |
p.G13A |
-1 |
Brose et al., 2002, Cancer Res. |
|
|
|
|
|
|
60 |
KRAS |
12p12.1 |
rs112445441 |
C/T |
missense |
p.G13D |
-1 |
Brose et al., 2002, Cancer Res. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|